Publication: Scabraside D extracted from Holothuria scabra induces apoptosis and inhibits growth of human cholangiocarcinoma xenografts in mice
Issued Date
2016-01-01
Resource Type
ISSN
15137368
Other identifier(s)
2-s2.0-84960372424
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Cancer Prevention. Vol.17, No.2 (2016), 511-517
Suggested Citation
Kanjana Assawasuparerk, Rapeepun Vanichviriyakit, Charoonroj Chotwiwatthanakun, Saksit Nobsathian, Thanakorn Rawangchue, Boonsirm Wittayachumnankul Scabraside D extracted from Holothuria scabra induces apoptosis and inhibits growth of human cholangiocarcinoma xenografts in mice. Asian Pacific Journal of Cancer Prevention. Vol.17, No.2 (2016), 511-517. doi:10.7314/APJCP.2016.17.2.511 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/43208
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Scabraside D extracted from Holothuria scabra induces apoptosis and inhibits growth of human cholangiocarcinoma xenografts in mice
Abstract
Scabraside D, a sulfated triterpene glycoside extract from sea cucumber Holothulia scabra, shows various biological activities, but effects on human cholangiocarcinoma cells have not previously been reported. In the present study, we investigated the activity of scabraside D against human cholangiocarcinoma (HuCCA) both in vitro and for tumor growth inhibition in vivo using a xenograft model in nude mice. Scabraside D (12.5-100 μg/mL) significantly decreased the viability and the migration of the HuCCA cells in a dose-dependent manner, with 50% inhibitory concentration (IC50) of 12.8 ± 0.05 μg/mL at 24 h. It induced signs of apoptotic cells, including shrinkage, pyknosis and karyorrhetic nuclei and DNA fragmentation on agarose gel electrophoresis. Moreover, by quantitative real-time PCR, scabraside D effectively decreased Bcl-2 while increasing Bax and Caspase-3 gene expression levels suggesting that the scabraside D could induce apoptosis in HuCCA cells. In vivo study demonstrated that scabraside D (1 mg/kg/day, i.p. for 21 days) significantly reduced growth of the HuCCA xenografts without adverse effects on the nude mice. Conclusively, scabraside D induced apoptosis in HuCCA cells and reduced the growth of HuCCA xenographs model. Therefore, scabraside D may have potential as a new therapeutic agent for cholangiocarcinoma.